Allan Doctor, MD
Disclosures: Intellectual property rights/patent holder-KaloCyte, Inc.,Ownership interest (excluding diversified mutual funds)-KaloCyte, Inc.,Supported/contracted research-KaloCyte, Inc. ,Royalties or honoraria-Fresenius Kabi AG,Ownership interest (excluding diversified mutual funds)-Etiometry, Inc.,Supported/contracted research-Entegrion, Inc.,Royalties or honoraria-Biogen Idec

Allan Doctor, MD is Professor of Pediatrics and Biochemistry & Molecular Biophysics at the Washington University School of Medicine and a Pediatric Intensivist at Saint Louis Children’s Hospital, where he led Critical Care for 10 years, stepping down in 2016 to focus on a rapidly expanding research program and on development of a novel bio-synthetic artificial red cell. His laboratory studies the role of red blood cell-based signaling in the control of regional blood flow, related pathophysiology arising from acquired red cell injuries, blood substitute design, and on translational transfusion medicine in critical illness.